GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

RNST · Jun 30, 2025

RENASANT CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000715072-25-000211Bank
Sequential deposit growth100thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

46.10% · CORE · VALID

Net-income growth0thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-97.38% · CORE · VALID

Interest-income growth90thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

56.17% · CORE · VALID

Cash and equivalents80thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$1.4B · CORE · VALID

Sequential loan growth100thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

42.18% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History37 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
1.37%
Current
46.10%
Delta
44.74%
Earnings Growth Decreased
Previous
5.35%
Current
-97.38%
Delta
-102.73%
Interest Income Growth Increased
Previous
3.35%
Current
56.17%
Delta
52.81%
Liquidity Increased
Previous
$1.1B
Current
$1.4B
Delta
$287.3M
Loan Growth Increased
Previous
1.33%
Current
42.18%
Delta
40.85%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.